Teva Pharma (TEVA) PT Lowered to $14 at Susquehanna
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $36.29 -0.19%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Join SI Premium – FREE
Susquehanna lowered its price target on Teva Pharma (NYSE: TEVA) to $14.00 (from $20.00) while maintaining a Positive rating.
Analyst Andrew Finkelstein notes Q3 showed further challenges.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Hyperion DeFi, Inc. (HYPD) PT Raised to $8.45 at Chardan
- Royalty Pharma (RPRX) PT Raised to $68 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
